» Articles » PMID: 29703019

Coffee Consumption and Risk of Esophageal Cancer Incidence: A Meta-analysis of Epidemiologic Studies

Overview
Specialty General Medicine
Date 2018 Apr 29
PMID 29703019
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In epidemiologic studies, association between coffee consumption and esophageal cancer risk is inconsistent.

Objective: The aim of tjis study was to evaluate the effect of coffee on esophageal cancer by combining several similar studies.

Methods: We conducted a meta-analysis for association of coffee intake and esophageal cancer incidence. Eleven studies, including 457,010 participants and 2628 incident cases, were identified. A relative risk (RR, for cohort study) or odds ratio (OR, for case-control study) of heavy coffee drinkers was calculated, compared with light coffee drinkers or non-drinkers. The analysis was also stratified by cancer types (esophageal squamous cell carcinoma and esophageal adenocarcinoma), sex, and geographic region.

Results: The summarized OR of having esophageal cancer in heavy coffee drinkers was 0.93 (95% confidence interval [CI]: 0.73-1.12), compared with light coffee drinkers. When stratified by sex, pathologic type of esophageal cancer, and type of epidemiologic study, we did not find any association of coffee consumption and esophageal cancer incidence. However, an inverse association between coffee consumption and incidence of esophageal cancer was found in East Asia participants with OR of 0.64 (95% CI: 0.44-0.83), but not in Euro-America participants (OR = 1.05; 95% CI: 0.81-1.29).

Conclusion: There is a protective role of coffee consumption against esophageal cancer in East Asians, but not in Euro-Americans.

Citing Articles

Exploring Dietary Factors and Esophageal Adenocarcinoma: Insights From Mendelian Randomization Study.

Liu X, Yang W, Yang Y Food Sci Nutr. 2024; 12(11):9600-9606.

PMID: 39620031 PMC: 11606852. DOI: 10.1002/fsn3.4527.


Caffeine: A Multifunctional Efficacious Molecule with Diverse Health Implications and Emerging Delivery Systems.

Song X, Singh M, Lee K, Vinayagam R, Kang S Int J Mol Sci. 2024; 25(22).

PMID: 39596082 PMC: 11593559. DOI: 10.3390/ijms252212003.


Coffee consumption, cancer, and healthy aging: epidemiological evidence and underlying mechanisms.

Kunutsor S, Lehoczki A, Laukkanen J Geroscience. 2024; .

PMID: 39266809 DOI: 10.1007/s11357-024-01332-8.


The relationship between caffeine consumption and colon cancer prevalence in a nationally representative population.

Qu Y, Cheng Y, Chen F Front Nutr. 2024; 11:1375252.

PMID: 38863582 PMC: 11165181. DOI: 10.3389/fnut.2024.1375252.


The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis.

Cai X, Li X, Liang C, Zhang M, Dong Z, Yu W Sci Rep. 2024; 14(1):9474.

PMID: 38658636 PMC: 11043381. DOI: 10.1038/s41598-024-60122-6.


References
1.
Fock K, Talley N, Fass R, Goh K, Katelaris P, Hunt R . Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008; 23(1):8-22. DOI: 10.1111/j.1440-1746.2007.05249.x. View

2.
Hongo M . Review article: Barrett's oesophagus and carcinoma in Japan. Aliment Pharmacol Ther. 2004; 20 Suppl 8:50-4. DOI: 10.1111/j.1365-2036.2004.02230.x. View

3.
Hedges L, Pigott T . The power of statistical tests in meta-analysis. Psychol Methods. 2001; 6(3):203-17. View

4.
Zintzaras E, Ioannidis J . Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2004; 28(2):123-37. DOI: 10.1002/gepi.20048. View

5.
Tavani A, Bertuzzi M, Talamini R, Gallus S, Parpinel M, Franceschi S . Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol. 2003; 39(7):695-700. DOI: 10.1016/s1368-8375(03)00081-2. View